Ph I Study of CB-03-10 with in Subjects with Advanced Solid Tumors
Farshid Dayyani
- IRB INITIAL APPROVAL
trials found matching your search:
Displaying 6 of 294 Results
PhIII Pirtobrutinib + Venetoclax & Rituximab vs Venetoclax & Rituximab in PrevTreated CLL/SLL
Susan O'Brien
- OPEN TO ACCRUAL
Ph I/II Selective RET Inhibitor TAS0953/HM06 in Pts w/ Adv Solid Tumors with RET Gene Abnormalities
Sai-Hong Ignatius Ou
- OPEN TO ACCRUAL
Study of inclisiran to prevent cardiovascular (CV) events in participants w/established CV disease.
Ailin Barseghian Elfarra
- OPEN TO ACCRUAL
PhII Combo Atelizumab&CDX-1127 w/ or w/o Add of Cobimetinib in Prev Treated Unresec Biliary Tract Ca
Farshid Dayyani
- OPEN TO ACCRUAL
Optimal Perioperative Therapy for Incidental Gallbladder Cancer (OPT-IN): A Randomized Phase II/III
Zeljka Jutric
- OPEN TO ACCRUAL